Notably, in non-small cell lung cancer cell models, elevated levels of EHD1 correlated with insensitivity to EGFR inhibition and such insensitivity was overcome by genetic depletion of EHD116. This evidence concerns the gene EHD1 and non-small cell lung carcinoma.